TELA Bio
TELA
42 hedge funds and large institutions have $32.5M invested in TELA Bio in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
8.89% more ownership
Funds ownership: 59.48% → 68.37% (+8.9%)
5% more funds holding
Funds holding: 40 → 42 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less capital invested
Capital invested by funds: $35.1M → $32.5M (-$2.61M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$4.56M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.62M |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$713K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$249K |
| 5 |
EFG
Embree Financial Group
Chicago,
Illinois
|
+$123K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$1.11M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$1.08M |
| 3 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$298K |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
-$231K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$171K |
TELA Hedge Fund Activity: Q4 2025 in Review
42 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q4 2025, worth a combined $32.5M — down 7.4% from $35.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TELA positions and 5 closed out — a net gain of 2 holders — while 12 added to existing stakes and 8 trimmed.
The largest buyer was Essex Woodlands Management, adding an estimated $4.56M. The largest seller was Velan Capital Investment Management, exiting entirely with an estimated $1.11M sold.
- 42 institutional investors held TELA Bio (TELA) as of Q4 2025, up from 40 in Q3 2025.
- Funds reported $32.5M of TELA Bio stock for Q4 2025, down 7.4% quarter-over-quarter.
- 7 funds opened new TELA Bio positions in Q4 2025 and 5 closed out, a net change of +2 holders.
- The largest TELA Bio buyer in Q4 2025 was Essex Woodlands Management, an estimated $4.56M added.
- The largest TELA Bio seller in Q4 2025 was Velan Capital Investment Management, an estimated $1.11M sold.
Based on aggregated 13F filings for Q4 2025.